Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Immune Checkpoint Inhibitors Reverse the Mesenchymal Stromal Cell-Mediated Immunosuppression in Acute Myeloid Leukemia Microenvironment

Rong Xin Liu, Meizhang Li, Harsh B. Pathak, Tara L. Lin, Barry S. Skikne, Joseph P. McGuirk, Omar Aljitawi, Andrew K. Godwin, Haitham Abdelhakim

Blood (2024) 144 (Supplement 1): 4065.

https://doi.org/10.1182/blood-2024-208946

Published: 2024

Journal Articles

Prognosis of NF1 Mutations in Acute Myeloid Leukemia

Joshua Tatarian, Stephen Hyter, Andrew K. Godwin, Daniel Farrell, Tara L. Lin, Haitham Abdelhakim

Blood (2022) 140 (Supplement 1): 3448–3449.

https://doi.org/10.1182/blood-2022-169834

Published: 2022

Journal Articles

LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing

Haitham Abdelhakim, MD, Luis M. Cortez, BS, Meizhang Li, PhD, Mitchell Braun, BS, Barry S. Skikne, MD, Tara L. Lin, MD, Neil Dunavin, MD, Andrew K Godwin, PhD

Blood (2019) 134 (Supplement_1): 3605.

https://doi.org/10.1182/blood-2019-129455

Published: 2019

Journal Articles

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature

Haitham Abdelhakim, MD, Ahmad Elkhanany, MD, Mohammad Telfah, MD, Tara L. Lin, MD, Andrew K Godwin, PhD

Blood (2019) 134 (Supplement_1): 1402.

https://doi.org/10.1182/blood-2019-131296

Published: 2019

Journal Articles

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

Neil Dunavin, MD, Meizhang Li, PhD, Safinur Atay, PhD, Jim Mitchell, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, Andrew K Godwin, PhD, Buddhadeb Dawn, MD

Blood (2018) 132 (Supplement 1): 5095.

https://doi.org/10.1182/blood-2018-99-116921

Published: 2018

Journal Articles

LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression

Haitham Abdelhakim, MD, Neil Dunavin, MD, Meizhang Li, PhD, Mitchell Braun, BS, Ahmed Elkhanany, MD, Tara L Lin, MD, Andrew K Godwin, PhD

Blood (2018) 132 (Supplement 1): 2414.

https://doi.org/10.1182/blood-2018-99-117784

Published: 2018

NARROW

Immune Checkpoint Inhibitors Reverse the Mesenchymal Stromal Cell-Mediated Immunosuppression in Acute Myeloid Leukemia Microenvironment

Prognosis of NF1 Mutations in Acute Myeloid Leukemia

LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression

Email alerts

ASH Publications

American Society of Hematology

Immune Checkpoint Inhibitors Reverse the Mesenchymal Stromal Cell-Mediated Immunosuppression in Acute Myeloid Leukemia Microenvironment

Prognosis of NF1 Mutations in Acute Myeloid Leukemia

LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature

CRISPR/Cas9-Mediated Disruption of PD-L1 Reduces the T Cell Suppressive Effect of Wharton's Jelly Mesenchymal Stromal Cells and Their Extracellular Vesicles

LAG3 Promotes Acute Myeloid Leukemia-Induced Immune Suppression

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only